Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Miji International Holdings Limited ( (HK:1715) ) has shared an update.
AI Health Technology Limited has announced board changes effective 12 January 2026, including the resignation of independent non-executive director Li Wei, who is stepping down from the board and the audit committee to focus on other business commitments. The company has moved to maintain independent oversight by re-designating existing non-executive director Zhang Yuanjie as an independent non-executive director, citing her lack of involvement in daily operations, absence of financial interests in the group, and compliance with Hong Kong listing independence criteria. Zhang, a seasoned corporate consultant with over 20 years of experience in investment, M&A and restructuring across the Asia-Pacific region, has signed a new one-year service contract with annual remuneration of HK$120,000 and will be subject to shareholder re-election, signaling the company’s effort to preserve governance continuity and independent judgment on the board following Li’s departure.
The most recent analyst rating on (HK:1715) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Miji International Holdings Limited stock, see the HK:1715 Stock Forecast page.
More about Miji International Holdings Limited
AI Health Technology Limited is a Cayman Islands-incorporated company listed on the Hong Kong Stock Exchange. The group operates in the health technology sector, with a focus on applying artificial intelligence and related digital solutions to healthcare and wellness services in its core markets.
Average Trading Volume: 1,236,061
Technical Sentiment Signal: Buy
Current Market Cap: HK$175M
Learn more about 1715 stock on TipRanks’ Stock Analysis page.